The role of intrahepatic lymphocytes in mediating protective immunity induced by attenuated Plasmodium berghei sporozoites

Immunological Reviews

Volumn 174, Issue , 2000, Pages 123-134

  Krzych, Urszula ^a   Schwenk, Robert ^a   Guebre Xabier, Mimi ^a   Sun, Peifang ^a   Palmer, Dupeh ^a   White, Katherine ^a   Chalom, Isaac ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MALARIA VACCINE; MONOCLONAL ANTIBODY; PARASITE ANTIGEN; PRIMAQUINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIMALARIAL ACTIVITY; APOPTOSIS; CELL DEATH; CELLULAR IMMUNITY; CONTROLLED STUDY; EFFECTOR CELL; FEEDBACK SYSTEM; HUMAN; IMMUNIZATION; INFECTION PREVENTION; IRRADIATION; KINETICS; KNOCKOUT MOUSE; LIFE CYCLE; LIVER CELL; LIVER PROTECTION; LONG TERM EXPOSURE; MALARIA; MATURATION; MONONUCLEAR CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PARASITE IMMUNITY; PLASMODIUM BERGHEI; PRIORITY JOURNAL; REVIEW; RODENT; SPLEEN; SPOROZOITE; T LYMPHOCYTE;

EID: 0034037819     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0528.2002.00013h.x     Document Type: Review

References (68)

1. 1. Nardin EH, Nussenzweig RS. T cell responses to pre-erythrocytic stages of malaria. Role in protection and vaccine development against pre-erythrocytic stages. Annu Rev Immunol 1993;11:687-727.
2. 2. Hoffman SL, Franke ED. Inducing protective immune responses against the sporozoites and liver stages of Plasmodium. Immunol Lett 1994;41:89-94.
3. 3. Day KP, Marsh K. Naturally acquired immunity to Plasmodium falciparum. Immunol Today 1991;12:A68-A71.
4. 4. Sturchler D. How much malaria is there worldwide? Parasitol Today 1989;5:39-40.
5. 5. Santoro F, et al. Structural similarities among the protective antigens of sporozoites from different species of malaria parasites. J Biol Chem 1983;258:3341-3345.
6. 6. Krzych U, Guebre-Xabier M, Schwenk R. Malaria and the liver: tolerance and immunity to attenuated Plasmodia sporozoites. In: Crispe IN, ed. T lymphocytes in the liver: immunobiology, pathology and host defense. New York: Wiley-Liss; 1999, p. 163-195.
7. 7. Nussenzweig V, Nussenzweig RS. Rationale for the development of an engineered sporozoite malaria vaccine. Adv Immunol 1989;45:283-334.
8. 8. Robson KJH, et al. A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite. Nature 1988;335:79-82.
9. 9. Rogers WO, Rogers MD, Hedstrom RC, Hoffman SL. Characterization of the gene encoding sporozoite surface protein 2, a protective Plasmodium yoelii sporozoite antigen. Mol Biochem Parasitol 1992;53:45-52.
10. 10. Sinnis P. The malaria sporozoite's journey into the liver. Infect Agents Dis 1996;5:182-189.
11. 11. Frevert U. Malaria sporozoite-hepatocyte interactions. Exp Parasitol 1994;79:206-210.
12. 12. Guerin-Marchand C, et al. A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning. Nature 1987;329:164-167.
13. 13. Holder AA. Preventing merozoite invasion of erythrocytes. In: Hoffman SL, ed. Malaria vaccine development: a multi-immune response approach. San Diego (CA): ASL Press; 1996. p. 77-92.
14. 14. Clyde DF, Most H, McCarthy VC, Vanderberg JP. Immunization of man against sporozoite-induced falciparum malaria. Am J Med Sci 1973;266:169-177.
15. 15. Rieckmann KH, Beaudoin RL, Cassells JS, Sell DW. Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria. Bull World Health Organ 1979;57 (Suppl 1):261-265.
16. 16. Nussenzweig RS, Vanderberg J, Most H, Orton C. Protective immunity produced by the injection of X-irraduted sporozoites of Plasmodium berghei. Nature 1967;216:160-162.
17. 17. Matzinger P. Tolerance, danger and the extended family. Annu Rev Immunol 1994;12:991-1045.
18. 18. Scheller LF, Azad AF. Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites. Proc Natl Acad Sci USA 1995;92:4066-4068.
19. 19. Bergmann ES, Ballou RW, Krzych U. CD4 T lymphocytes producing IL-4 in response to Plasmodium falciparum parasitized red blood cells: an in vitro correlate of a protective immune response? Cell Immunol 1997;180:143-152.
20. 20. Alfrey E, et al. Interferon-γ and interleukin-10 messenger RNA are up-regulated after orthotopic liver transplantation in tolerant rats: evidence for cytokine-mediated immune dysregulation. Surgery 1995;118:399-405.
21. 21. Limmer A, et al. Failure to induce organ-specific autoimmunity by breaking of tolerance: importance of the microenvironment. Eur J Immunol 1998;28:2395-2406.
22. 22. Sedegah M, Finkelman F, Hoffman SL. Interleukin-12 induction of interferon-γ-dependent protection against malaria. Proc Natl Acad Sci USA 1994;91:10700-10702.
23. 23. White KL, Jarboe DL, Krzych U. Immunization with irradiated Plasmodium berghei sporozoites induces IL-2 and IFN-γ but not IL-4. Parasite Immunol 1994;16:479-491.
24. 24. Qian S, et al. Apoptosis within spontaneously accepted mouse liver allografts. J Immunol 1997;158:4654-4661.
25. 25. Mellouk S, et al. Inhibitory activity of interferons and interleukin-1 on the development of Plasmodium falciparum in human hepatocyte cultures. J Immunol 1987;139:4192-4195.
26. 26. Ferreira A, et al. Inhibition of development of exoerythrocytic forms of malaria parasites by γ-interferon. Science 1986;232:881-884.
27. + T cells and antibodies are required for immunity to malaria sporozoites. Nature 1987;330:664-666.
28. 28. Tsuji M, et al. Development of antimalaria immunity in mice lacking IFN-γ receptor. J Immunol 1995;154:5338-5344.
29. + cytolytic T cell clones confers protection against murine malaria. J Exp Med 1990;172:1353-1357.
30. 30. Suhrbier, A. Immunity to liver stages of malaria. Parasitol Today 1991;7:160-163.
31. 31. Khan ZM, Vanderberg JP. Specific inflammatory cell infiltration of hepatic schizonts in BALB/c mice immunized with attenuated Plasmodium yoelii sporozoites. Int Immunol 1992;4:711-718.
32. 32. Khan ZM, Vanderberg JP. Eosinophil-rich, granulomatous inflammatory response to Plasmodium berghei hepatic schizonts in non immunized rats is age-related. Am J Trop Med Hyg 1991;45:190-201.
33. + T cells surrounding malaria infected hepatocytes. Infect Immunol 1997;65:3882-3888.
34. 34. Faure P, Marussig M, Goossens P, Miltgen F, Mazier D. Characterization of liver lymphomyeloid cells in mice infected with Plasmodium yoelii sporozoites. Immunology 1994;82:645-650.
35. + T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc Natl Acad Sci USA 1988;185:573-576.
36. 36. Malik A, Egan JE, Houghten RA, Sadoff JC, Hoffman SL. Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. Proc Natl Acad Sci USA 1991;88:3300-3304.
37. 37. Kumar S, et al. Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum. Nature 1988;334:258-260.
38. 38. Krzych U, et al. Role of circumsporozoite protein-specific T-cells in protective immunity against Plasmodium berghei. Bull World Health Organ 1990;68 (Suppl):88-93.
39. 39. Khusmith S, Charoenvit Y, Kumar S, Sedegah M, Beaudoin RL, Hoffman SL. Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. Science 1991;252:715-718.
40. + cytotoxic T-cell clone recognizing sporozoite surface protein 2. Infect Immun 1994;62:2979-2983.
41. 41. Wizel B, et al. HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein-2 epitopes in sporozoite-immunized volunteers. J Immunol 1995;155:766-775.
42. 42. Romero P, Maryanski JL, Corradin G, Nussenzweig RS, Nussenzweig V, Zavala F. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 1989;341:323-326.
43. + T cell clones correlates with their levels of expression of adhesion molecules. J Exp Med 1992;175:895-905.
44. + T lymphocytes is required for protective immunity against Plasmodium berghei. J Immunol 1997;156:3374-3381.
45. 45. Renggli J, Hahne M, Matile H, Betschart B, Tschopp J, Corradin GP. Elimination of P. berghei liver stages is independent of Fas (CD95/Apo-1) or perforin-mediated cytotoxicity. Parasite Immunol 1997;19:145-148.
46. + T cells persist in livers of mice protected against malaria by immunization with attenuated Plasmodium berghei sporozoites. Eur J Immunol 1999;29:3978-3986.
47. 47. Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science 1996;272:54-60.
48. 48. Cerwenka A, Carter L, Reome J, Swain S, Dutton R. In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines. J Immunol 1998;161:97-105.
49. + T cells in immunity to malaria sporozoites. J Immunol 1993;151:2690-2698.
50. 50. Krzych U, Jareed T, Link HT, Loomis LD, Ballou WR. Distinct T cell specificities are induced with the authentic versus recombinant Plasmodium berghei circumsporozoite protein. J Immunol 1992;148:2530-2538.
51. 51. Link HT, White K, Krzych U. Plasmodium berghei-specific T cells respond to non-processed sporozoites presented by B cells. Eur J Immunol 1993;23:2263-2269.
52. + T cells. J Immunol 1990;144:3288-3295.
53. 53. Crispe IN, Mehal WZ. Strange brew: T cells in the liver. Immunol Today 1996;17:522-525.
54. + cells: new clues to their origin, specificity and function. J Exp Med 1995;182:633-638.
55. + T cells: a new family of T cells. Immunol Today 1996;17:71-76.
56. + T cells by CD1-expressing cortical thymocytes. J Exp Med 1995;182:2091-2096.
57. + T cells promptly produce interleukin-4 in response to in vivo challenge with anti-CD3. J Exp Med 1994;179:1285-1295.
58. + αβ T cells with intermediate TCR induced in the liver of mice by IL-12. J Immunol 1995;154:4333-4340.
59. 59. O'Farrelly C, Crispe N. Prometheus through the looking glass: reflections on the hepatic immune system. Immunol Today 1999;20:394-398.
60. + TCRαβ intermediate liver lymphocytes are down regulated by Listeria monocytogenes. Eur J Immunol 1995;25:3321-3325.
61. + αβ T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis. J Immunol 1996;156:3366-3373.
62. 62. Kaufman SHE. Immunity to intracellular bacteria. Annu Rev Immunol 1993;11:129-165.
63. + T cells reactive with Plasmodium chabaudi chabaudi I: distinct response kinetics of cells with Th1 and Th2 characteristics during infection. Int Immunol 1989;1:416-424.
64. 64. Zinkernagel R, et al. On immunological memory. Annu Rev Immunol 1996;14:333-367.
65. 65. DeSouza Leao S, Lang T, Prina E, Hellio R, Antoine J-C. Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC clas II molecules in their host cells. J Cell Sci 1995;108:3219-3231.
66. 66. Krzych U, et al. T lymphocytes from volunteers immunized with irradiated Plasmodium falciparum sporozoites recognize liver and blood stage malaria antigens. J Immunol 1995;155:4072-4077.
67. 67. Lynch DH, Ramsdell F, Alderson MR. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 1995;16:569-574.
68. 68. Galle PR, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995;182:1223-1230.